Larvol Delta - The-Clinical-Study-of-CD20-CART-Cells-in-Patients-With-Relapsed-and-Refractory-B-Cell-NonHodgkin-Lymphoma

CD20 CAR-T cells therapy - Shanghai Longyao Biotech

http://clinicaltrials.gov/ct2/show/NCT04169932

Nov 20, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev